Convergence Financial’s Merck MRK Stock Holding History
Bought
Maintained
Sold
Other funds holding MRK
Convergence Financial's MRK Position: Q2 2026 in Review
Convergence Financial reduced its Merck (MRK) stake by 12% in Q2 2026, selling an estimated $326K and leaving 19,556 shares worth $2.51M. The position accounts for 0.2% of the portfolio, ranked #71.
Convergence Financial first reported a position in MRK in Q2 2024 and has held it in 9 quarters since. The position peaked at $2.69M in Q1 2026. 3,833 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- Convergence Financial held 19,556 shares of Merck worth $2.51M as of Q2 2026.
- Convergence Financial sold 2,784 Merck shares in Q2 2026, an estimated $326K.
- Merck made up 0.2% of Convergence Financial's portfolio in Q2 2026, its #71 holding.
- Convergence Financial first reported a position in Merck in Q2 2024 and has held it in 9 quarters since.
- Convergence Financial's Merck position peaked at $2.69M in Q1 2026.
- 3,833 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on Convergence Financial's 13F filing for Q2 2026, filed 5 Aug 2026.